mesalamine has been researched along with Day Blindness in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a case of benign intracranial hypertension related to mesalazine use." | 1.32 | Mesalazine-associated benign intracranial hypertension in a patient with ulcerative colitis. ( Giamundo, A; Iaccarino, G; Jura, A; Romano, A; Rosa, N, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosa, N | 1 |
| Giamundo, A | 1 |
| Jura, A | 1 |
| Iaccarino, G | 1 |
| Romano, A | 1 |
1 other study available for mesalamine and Day Blindness
| Article | Year |
|---|---|
Mesalazine-associated benign intracranial hypertension in a patient with ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Headache; Humans; Mesal | 2003 |